Stocktoria
Spyre Therapeutics, Inc. SYRE
Spyre Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 2,403,441 | $56.5M | 3.07% |
| MILLENNIUM MANAGEMENT LLC | 196,712 | $17.5M | 0.25% |
| CITADEL ADVISORS LLC | 154,800 | $13.7M | 0.2% |
| D. E. Shaw & Co., Inc. | 26,452 | $2.3M | 0.03% |
| AQR CAPITAL MANAGEMENT LLC | 22,937 | $2.0M | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 12,771 | $1.1M | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.